| # | Drug | Count |
|---|---|---|
| 0 | DABIGATRAN ETEXILATE MESYLATE | 121 |
| 1 | DABIGATRAN ETEXILATE | 117 |
| 2 | ASPIRIN | 14 |
| 3 | ASPIRIN 325 MG | 14 |
| 4 | ASPIRIN 81 MG | 14 |
| 5 | METOPROLOL | 11 |
| 6 | METOPROLOL TARTRATE | 11 |
| 7 | PANTOPRAZOLE | 11 |
| 8 | SIMVASTATIN | 11 |
| 9 | TIGECYCLINE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDARUCIZUMAB | 6 | 0.0042 |
| 1 | TIGECYCLINE | 11 | 0.0018 |
| 2 | ONASEMNOGENE ABEPARVOVEC-XIOI | 4 | 0.0017 |
| 3 | DABIGATRAN ETEXILATE MESYLATE | 121 | 0.0017 |
| 4 | DABIGATRAN ETEXILATE | 117 | 0.0015 |
| 5 | ARGATROBAN | 2 | 0.0013 |
| 6 | SELUMETINIB | 2 | 0.0012 |
| 7 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 8 | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | 1 | 0.0008 |
| 9 | ZINC SULFATE INJECTION, | 2 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 6 | 0.0042 |
| 1 | Tetracycline-class Antibacterial [EPC] | 11 | 0.0014 |
| 2 | Anti-coagulant [EPC] | 2 | 0.0005 |
| 3 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 4 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 5 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Bismuth [EPC] | 1 | 0.0002 |
| 7 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |